advertisement
Abstract #94853 Published in IGR 22-2
Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Phillips MJ; Dinh-Dang D; Bolo K; Burkemper B; Lee JC; LeTran VH; LeTran VH; Chang BR; Grisafe DJ; Chu Z; Zhou X; Song BJ; Xu BY; Wong B; Wang RK; Richter GMAmerican Journal of Ophthalmology 2021; 231: 58-69
PURPOSE: To compare dynamic ranges and steps to measurement floors of peripapillary and macular metrics from a complex signal-based optical microangiography (OMAG) optical coherence tomography angiography (OCTA) device for glaucoma with those of OCT measurements. DESIGN: Cross-sectional study. METHODS: Imaging of 252 eyes from 173 patients with glaucoma and 123 eyes from 92 subjects without glaucoma from a glaucoma clinic was quantified using custom and commercial software. Metrics from OCT (retinal nerve fiber layer [RNFL], ganglion cell/inner plexiform layer [GCIPL]) and OCTA (custom: peripapillary vessel area density [pVAD], macular vessel area density [mVAD], and macular vessel skeleton density [mVSD]; commercial: peripapillary perfusion density [pPD], macular perfusion density [mPD], and macular vessel density [mVD]) were plotted against visual field mean deviation (MD) with linear change-point analyses, measurement floors, and steps to floors. RESULTS: Mean MD (dB) for glaucomatous eyes was -5.77 (-6.45 to -5.10). The number of eyes with mild glaucoma (MD >-6), moderate glaucoma (MD -6 to -12), and severe glaucoma (MD <-12) were 164, 50, and 38, respectively. pPD yielded the lowest estimated floor at -26.6 dB (standard error [SE] 1.53), followed by OCTA macular metrics (-25 to -21 dB; SE 1.03) and pVAD (-17.6 dB, SE 1.06). RNFL and GCIPL produced floors at -17.8 (SE 0.927) and -23.6 dB (SE 1.14). The highest number of steps to measurement floor belonged to RNFL (7.20) and GCIPL (7.33), followed by pPD (4.25), mVAD (3.87), and mVSD (3.81), with 2.5 or fewer steps for pVAD, mPD, and mVD. CONCLUSIONS: pPD, mVAD, and mVSD had approximately 4 steps within their dynamic ranges, without true measurement floors, and thus may be useful in evaluating advanced glaucomatous progression. Improving OCTA test-retest repeatability could augment number of steps for OCTA metrics, increasing their clinical utility.
Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Full articleClassification:
6.9.2.2 Posterior (Part of: 6 Clinical examination methods > 6.9 Computerized image analysis > 6.9.2 Optical coherence tomography)
6.11 Bloodflow measurements (Part of: 6 Clinical examination methods)
6.6.2 Automated (Part of: 6 Clinical examination methods > 6.6 Visual field examination and other visual function tests)
6.20 Progression (Part of: 6 Clinical examination methods)
